目的 对数字健康技术在乳腺癌患者内分泌治疗依从性中应用的研究进行范围审查，为优化相关干预策略提供参考依据。 方法 根据范围综述方法学框架，检索中国知网、万方、PubMed、Embase等中英文数据库中数字健康技术提升乳腺癌内分泌治疗依从性的相关研究并分析，检索时限为建库至2024年6月1日。 结果 共纳入14项相关研究，干预措施包括移动应用程序、远程监测系统和基于网络平台的直接观察疗法。数字健康技术极大地促进了个人和医疗保健专业人员的疾病管理。然而，只有少数研究涉及双向沟通疗法，例如交互式短信和反馈系统。 结论 数字健康技术可有效改善乳腺癌患者内分泌治疗的依从性，但需进一步开发个性化的护理干预方案，强化长期疗效验证并建立精准化用药评估体系，以提升临床转化价值。

Objective To conduct a scoping review of studies on the application of digital health technologies in improving adherence to endocrine therapy in breast cancer patients，and to serve as a reference for optimizing relevant intervention strategies.Methods Based on the methodological framework of scoping review，relevant studies on the use of digital health technologies in improving adherence to endocrine therapy in breast cancer patients in Chinese and English databases were searched，including CNKI，Wanfang，PubMed，and Embase，from the inception of the databases to June 1，2024.Results A total of 14 relevant studies were included.The intervention measures included mobile applications，remote monitoring systems，and directly observed therapy based on web platforms.Digital health technologies greatly facilitated disease management for both individuals and healthcare professionals.However，only a few studies involved two-way communication therapies，such as interactive text messaging and feedback systems.Conclusions Digital health technologies can effectively improve adherence to endocrine therapy in breast cancer patients.However，there is a need to further develop personalized nursing intervention plans，strengthen long-term efficacy validation，and establish precise medication assessment systems to enhance clinical translation value.

R473.73;R47-0